The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABG ACQUISITION CORP I | CL A SHS | G00496102 | 252 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
| APOLLO COML REAL ESTATE FIN | NOTE 5.375%10/1 | 03762UAC9 | 3,257 | 3,349,000 | PRN | SOLE | 3,349,000 | 0 | 0 | |||
| ATLAS AIR WORLDWIDE HLDGS IN | NOTE 1.875% 6/0 | 049164BJ4 | 12,098 | 7,250,000 | PRN | SOLE | 7,250,000 | 0 | 0 | |||
| BLACKSTONE MORTGAGE TRUST IN | NOTE 4.750% 3/1 | 09257WAC4 | 9,647 | 9,838,000 | PRN | SOLE | 9,838,000 | 0 | 0 | |||
| CARTESIAN GROWTH CORP II | *W EXP 07/12/202 | G19305120 | 91 | 402,500 | SH | SOLE | 402,500 | 0 | 0 | |||
| COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 249 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
| DA32 LIFE SCNCE TEC ACQSTN C | CLASS A COM | 23312M106 | 248 | 25,003 | SH | SOLE | 25,003 | 0 | 0 | |||
| DIGITALBRIDGE GROUP INC | NOTE 5.000% 4/1 | 19624RAA4 | 6,091 | 6,184,000 | PRN | SOLE | 6,184,000 | 0 | 0 | |||
| ELEVANCE HEALTH INC | NOTE 2.750%10/1 | 94973VBG1 | 2,351 | 350,000 | PRN | SOLE | 350,000 | 0 | 0 | |||
| FINTECH EVOLUTION ACQUIS GRO | SHS CL A | G3R19A104 | 58 | 5,705 | SH | SOLE | 5,705 | 0 | 0 | |||
| HOPE BANCORP INC | NOTE 2.000% 5/1 | 43940TAB5 | 7,737 | 7,919,000 | PRN | SOLE | 7,919,000 | 0 | 0 | |||
| ILLUMINA INC | NOTE 8/1 | 452327AK5 | 1,246 | 1,290,000 | PRN | SOLE | 1,290,000 | 0 | 0 | |||
| INNOVIVA INC | NOTE 2.125% 1/1 | 88338TAB0 | 4,228 | 4,233,000 | PRN | SOLE | 4,233,000 | 0 | 0 | |||
| INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 1,139 | 1,162,000 | PRN | SOLE | 1,162,000 | 0 | 0 | |||
| KKR REAL ESTATE FIN TR INC | NOTE 6.125% 5/1 | 48251KAB6 | 10,957 | 11,164,000 | PRN | SOLE | 11,164,000 | 0 | 0 | |||
| LIGAND PHARMACEUTICALS INC | NOTE 0.750% 5/1 | 53220KAF5 | 13 | 13,000 | PRN | SOLE | 13,000 | 0 | 0 | |||
| NEW RELIC INC | NOTE 0.500% 5/0 | 64829BAB6 | 70 | 72,000 | PRN | SOLE | 72,000 | 0 | 0 | |||
| NOVAVAX INC | NOTE 3.750% 2/0 | 670002AB0 | 19,588 | 19,748,000 | PRN | SOLE | 19,748,000 | 0 | 0 | |||
| NUTANIX INC | NOTE 1/1 | 67059NAB4 | 1,873 | 1,902,000 | PRN | SOLE | 1,902,000 | 0 | 0 | |||
| OPPFI INC | COM CL A | 68386H103 | 122 | 59,438 | SH | SOLE | 59,438 | 0 | 0 | |||
| OPPFI INC | *W EXP 07/20/202 | 68386H111 | 3 | 29,719 | SH | SOLE | 29,719 | 0 | 0 | |||
| PATRICK INDS INC | DBCV 1.000% 2/0 | 703343AB9 | 419 | 423,000 | PRN | SOLE | 423,000 | 0 | 0 | |||
| PROFRAC HLDG CORP | CLASS A COM | 74319N100 | 206 | 8,164 | SH | SOLE | 8,164 | 0 | 0 | |||
| REDWOOD TRUST INC | NOTE 4.750% 8/1 | 758075AC9 | 99 | 100,000 | PRN | SOLE | 100,000 | 0 | 0 | |||
| SHATTUCK LABS INC | COM | 82024L103 | 91 | 39,467 | SH | SOLE | 39,467 | 0 | 0 | |||
| SILK RD MED INC | COM | 82710M100 | 8 | 146 | SH | SOLE | 146 | 0 | 0 | |||
| SLAM CORP | CL A SHS | G8210L105 | 254 | 25,100 | SH | SOLE | 25,100 | 0 | 0 | |||
| STARWOOD PPTY TR INC | NOTE 4.375% 4/0 | 85571BAH8 | 6,436 | 6,639,000 | PRN | SOLE | 6,639,000 | 0 | 0 | |||
| SUPERNUS PHARMACEUTICALS | NOTE 0.625% 4/0 | 868459AD0 | 4,023 | 4,095,000 | PRN | SOLE | 4,095,000 | 0 | 0 | |||
| TERADYNE INC | NOTE 1.250%12/1 | 880770AG7 | 2,852 | 1,352,000 | PRN | SOLE | 1,352,000 | 0 | 0 | |||
| TILRAY BRANDS INC | NOTE 5.000%10/0 | 88688TAB6 | 231 | 235,000 | PRN | SOLE | 235,000 | 0 | 0 | |||
| TWO | COM CL A | G9152V101 | 252 | 25,003 | SH | SOLE | 25,003 | 0 | 0 | |||
| VECTOR ACQUISITION CORP II | CL A SHS | G9460A104 | 171 | 16,888 | SH | SOLE | 16,888 | 0 | 0 | |||
| VEECO INSTRS INC DEL | NOTE 2.700% 1/1 | 922417AD2 | 196 | 199,000 | PRN | SOLE | 199,000 | 0 | 0 | |||